Robert Małecki

931 total citations
14 papers, 69 citations indexed

About

Robert Małecki is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert Małecki has authored 14 papers receiving a total of 69 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert Małecki's work include Renal Diseases and Glomerulopathies (4 papers), Chronic Kidney Disease and Diabetes (2 papers) and Diabetes Treatment and Management (2 papers). Robert Małecki is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Chronic Kidney Disease and Diabetes (2 papers) and Diabetes Treatment and Management (2 papers). Robert Małecki collaborates with scholars based in Poland, United States and Germany. Robert Małecki's co-authors include Łukasz Zapała, Artur A. Antoniewicz, Stanisław Niemczyk, Sándor Ferenczi, Alex Mercer, Monika Wieliczko, Marian Klinger, Priscila Preciado, Man Li and Jacek Imiela and has published in prestigious journals such as Scientific Reports, Brain Research and Journal of the American Society of Nephrology.

In The Last Decade

Robert Małecki

13 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Małecki Poland 6 34 17 10 10 9 14 69
Sheng Kuo United States 3 42 1.2× 17 1.0× 6 0.6× 4 0.4× 5 0.6× 4 59
Joanne Laycock United Kingdom 2 42 1.2× 13 0.8× 2 0.2× 11 1.1× 19 2.1× 3 82
Jonathan J. Hogan United States 4 50 1.5× 24 1.4× 5 0.5× 6 0.6× 9 1.0× 9 81
Sachiko Fukase Japan 4 36 1.1× 7 0.4× 9 0.9× 24 2.4× 5 0.6× 9 77
Helena Viana Portugal 6 29 0.9× 12 0.7× 9 0.9× 2 0.2× 5 0.6× 32 59
Cynthia McAllister United States 3 17 0.5× 5 0.3× 4 0.4× 10 1.0× 22 2.4× 3 60
Gaëtan Lebrun France 4 23 0.7× 12 0.7× 22 2.2× 28 2.8× 35 3.9× 9 93
Matthew C. Breeggemann United States 3 54 1.6× 16 0.9× 3 0.3× 13 1.3× 27 3.0× 7 101
Andrea Campo Italy 3 14 0.4× 25 1.5× 7 0.7× 7 0.7× 3 0.3× 6 41

Countries citing papers authored by Robert Małecki

Since Specialization
Citations

This map shows the geographic impact of Robert Małecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Małecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Małecki more than expected).

Fields of papers citing papers by Robert Małecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Małecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Małecki. The network helps show where Robert Małecki may publish in the future.

Co-authorship network of co-authors of Robert Małecki

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Małecki. A scholar is included among the top collaborators of Robert Małecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Małecki. Robert Małecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Kooienga, Laura, et al.. (2024). Concomitant Sparsentan (SPAR) and SGLT2 Inhibitors in Patients with IgA Nephropathy in the PROTECT Open-Label Extension (OLE). Journal of the American Society of Nephrology. 35(10S). 2 indexed citations
3.
4.
Kooienga, Laura, Robert Małecki, Priscila Preciado, Ping He, & Alex Mercer. (2023). Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients with IgA Nephropathy (IgAN) in the PROTECT Open-Label Extension (OLE). Journal of the American Society of Nephrology. 34(11S). 979–979. 2 indexed citations
5.
Saracyn, Marek, Bartłomiej Kisiel, Maria Franaszczyk, et al.. (2021). Diabetic kidney disease: Are the reported associations with single-nucleotide polymorphisms disease-specific?. World Journal of Diabetes. 12(10). 1765–1777. 1 indexed citations
6.
Pamporaki, Christina, Aleksander Prejbisz, Robert Małecki, et al.. (2021). Optimized procedures for testing plasma metanephrines in patients on hemodialysis. Scientific Reports. 11(1). 14706–14706. 5 indexed citations
7.
Perkowska‐Ptasińska, Agnieszka, Dominika Dęborska−Materkowska, Tomasz Stompór, et al.. (2016). Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrology. 17(1). 194–194. 28 indexed citations
8.
Antoniewicz, Artur A., et al.. (2015). The standard of urological consultation of patients qualified for renal transplant – a review. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 68(3). 376–82. 9 indexed citations
9.
Roger, Simon D., Е. В. Колмакова, Maple M. Fung, et al.. (2014). Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis. Nephrology. 19(5). 266–274. 5 indexed citations
10.
Jones, Michelle L., et al.. (2011). PI 3-kinase and PKCζ mediate insulin-induced potentiation of NMDA receptor currents in Xenopus oocytes. Brain Research. 1432. 7–14. 8 indexed citations
11.
Imiela, Jacek, et al.. (2009). [Position paper of the Working Group of Three Polish National Consultants in internal medicine, gastroenterology and cardiology concerning the rules of gastrointestinal complications' prevention during antiplatelet treatment].. PubMed. 67(5). 536–8. 1 indexed citations
12.
Małecki, Robert, et al.. (2004). [Heart failure in advanced age].. PubMed. 112 Spec No. 125–38. 1 indexed citations
13.
Małecki, Robert. (2000). [Hyperhomocysteinemia as a risk factor for cardiovascular diseases in patients with chronic renal failure].. PubMed. 104(4). 695–701. 1 indexed citations
14.
Imiela, Jacek, et al.. (1994). Disturbances of T‐cell interactions with endothelium and the extracellular matrix proteins in a patient with Takayasu arteritis. Journal of Internal Medicine. 235(6). 609–612. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheng Kuo Breakdown of academic impact, for papers by Joanne Laycock Breakdown of academic impact, for papers by Jonathan J. Hogan Breakdown of academic impact, for papers by Sachiko Fukase Breakdown of academic impact, for papers by Helena Viana Breakdown of academic impact, for papers by Cynthia McAllister Breakdown of academic impact, for papers by Gaëtan Lebrun Breakdown of academic impact, for papers by Matthew C. Breeggemann Breakdown of academic impact, for papers by Andrea Campo
Rankless by CCL
2026